Viewing StudyNCT00418938



Ignite Creation Date: 2024-05-05 @ 5:14 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00418938
Status: COMPLETED
Last Update Posted: 2018-10-17
First Post: 2007-01-04

Brief Title: SPIRITT - Second-Line Panitumumab Irinotecan Treatment Trial
Sponsor: Amgen
Organization: Amgen

Conditions & Keywords Data

Conditions:
Name
Metastatic Colorectal Cancer
Cancer
Colon Cancer
Colorectal Cancer
Metastatic Cancer
Rectal Cancer
Keywords:
Name View
EGFR View
FOLFIRI View
2nd Line Therapy View
2nd Line mCRC Therapy View
mCRC View
Irinotecan View
panitumumab View
bevacizumab View